IQAI vs. TRLS, INHC, FDBK, APTA, HELD, FAB, OCTP, IXI, DEMG, and VAL
Should you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Trellus Health (TRLS), Induction Healthcare Group (INHC), Feedback (FDBK), Aptamer Group (APTA), Hellenic Dynamics (HELD), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), Deltex Medical Group (DEMG), and ValiRx (VAL). These companies are all part of the "medical" sector.
IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.
IQ-AI has higher revenue and earnings than Trellus Health.
IQ-AI has a beta of 2.94, suggesting that its share price is 194% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.18, suggesting that its share price is 82% less volatile than the S&P 500.
Trellus Health has a net margin of 0.00% compared to IQ-AI's net margin of -85.53%. Trellus Health's return on equity of -29.34% beat IQ-AI's return on equity.
IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users.
In the previous week, IQ-AI had 5 more articles in the media than Trellus Health. MarketBeat recorded 5 mentions for IQ-AI and 0 mentions for Trellus Health. IQ-AI's average media sentiment score of 0.61 beat Trellus Health's score of 0.00 indicating that IQ-AI is being referred to more favorably in the media.
2.4% of IQ-AI shares are owned by institutional investors. Comparatively, 13.5% of Trellus Health shares are owned by institutional investors. 35.8% of IQ-AI shares are owned by company insiders. Comparatively, 57.5% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Trellus Health beats IQ-AI on 7 of the 12 factors compared between the two stocks.
Get IQ-AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
